Fabio Rodrigues Kerbauy
Overview
Explore the profile of Fabio Rodrigues Kerbauy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
da Silva D, Duarte B, de Oliveira Y, Piaia C, Aragao J, Chapchap E, et al.
Clin Lymphoma Myeloma Leuk
. 2024 Dec;
PMID: 39643564
Background: T-cell acute lymphoblastic leukemia (T-ALL) remains understudied compared to B-cell ALL, especially in Latin America. Different biology and response to chemotherapy have been described. Methods: This retrospective multi-site cohort...
2.
de Souza I, Cappellano P, Ferreira D, Bergamasco M, das Chagas Neto T, Kerbauy F, et al.
PLoS One
. 2024 Jan;
19(1):e0297161.
PMID: 38277372
Bacterial bloodstream infections (BSI) are a common threat among patients with haematological malignancies (HM) and hematopoietic stem cell transplant recipients (HSCT). The purpose of this research was to describe clinical...
3.
de Oliveira Marques M, Gomes N, de Andrade Young P, de Oliveira Marques O, Kerbauy F, Sandes A
Ann Hematol
. 2023 Mar;
102(8):2275-2276.
PMID: 36939867
No abstract available.
4.
Pessoa J, da Rosa E, Americo A, Motta C, de Oliveira C, Concilio R, et al.
Bone Marrow Transplant
. 2022 May;
57(8):1313-1318.
PMID: 35637267
The use of non-cryopreserved hematopoietic stem cells (HSC) can be an alternative to the traditional cryopreserved infusions of HSCs in autologous stem cell transplantation (aHSCT). After high-dose melphalan conditioning (HDM),...
5.
Esteves I, Santos F, Ribeiro A, Seber A, Sugawara E, Sobrinho J, et al.
Hematol Oncol
. 2020 Aug;
38(5):773-781.
PMID: 32779746
Busulfan is given in the conditioning regimens preceding hematopoietic stem cell transplantation (HSCT), and plasma levels can be monitored. A targeted, individualized systemic exposure (SE) dose can be achieved by...
6.
Thome C, Ferreira G, Pereira-Martins D, Augusto Dos Santos G, Ortiz C, de Souza L, et al.
Sci Rep
. 2020 Jun;
10(1):10315.
PMID: 32587277
Non-T cell activation linker (NTAL) is a lipid raft-membrane protein expressed by normal and leukemic cells and involved in cell signaling. In acute promyelocytic leukemia (APL), NTAL depletion from lipid...
7.
Chapchap E, Kerbauy L, Esteves I, Belucci T, Rodrigues M, Kerbauy F, et al.
Eur J Cancer Care (Engl)
. 2019 Jul;
28(5):e13122.
PMID: 31257689
Objectives: To analyse clinical outcomes comparing two age groups of patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT), and to identify risk factors associated with older patients' mortality. Methods: In...
8.
Esteves I, Santos F, Fernandes J, Seber A, Oliveira J, Hamerschlak N, et al.
Bone Marrow Transplant
. 2019 May;
54(11):1799-1804.
PMID: 31089278
Busulfan is used in myeloablative schemes for hematopoietic stem cell transplantation (HSCT), with monitoring of dosage through the area under the curve (AUC) of the drug plasma concentration (µMol min)....
9.
Kerbauy L, Kerbauy M, Bautzer V, Chapchap E, de Mattos V, Rocha J, et al.
Transpl Infect Dis
. 2019 May;
21(5):e13101.
PMID: 31054192
Background: BK polyomavirus reactivation can occur following allogeneic hematopoietic stem cell transplantation (allo-HSCT) and may lead to hemorrhagic cystitis (BKPyV-HC). We hypothesized that development of BKPyV-HC is associated with increased...
10.
Fernandes J, Bonfim C, Kerbauy F, Rodrigues M, Esteves I, Silva N, et al.
Bone Marrow Transplant
. 2018 Jan;
53(4):392-399.
PMID: 29330393
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only treatment that enhances survival and stabilizes neurologic symptoms in X-linked adrenoleukodystrophy (X-ALD) with cerebral involvement, a severe demyelinating disease of childhood....